Pharma & Healthcare
Global Inhaled Nitric Oxide Market Research Report 2025
- Jun 11, 25
- ID: 27652
- Pages: 67
- Figures: 69
- Views: 12
The global market for Inhaled Nitric Oxide was valued at US$ 649 million in the year 2024 and is projected to reach a revised size of US$ 940 million by 2031, growing at a CAGR of 6.1% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Inhaled Nitric Oxide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Inhaled Nitric Oxide (iNO) is a gas therapy widely used in the treatment of respiratory diseases, particularly neonatal respiratory distress syndrome (NRDS) and acute respiratory distress syndrome (ARDS) in adults. As a vasodilator, nitric oxide works by dilating the small blood vessels in the lungs, improving the matching of ventilation and blood flow in the alveoli, which in turn enhances oxygenation and reduces pulmonary arterial pressure. The therapeutic mechanism of inhaled nitric oxide primarily relies on its direct action on the smooth muscle of the pulmonary vessels, promoting the release of nitric oxide and thereby improving the vessel's ability to dilate, effectively improving the patient's oxygenation and respiratory function.
Currently, the products of inhaled nitric oxide mainly consist of gas formulations and related delivery devices, such as inhalers and gas concentration regulation systems. These products have been approved in many countries and regions and are widely used in neonatal intensive care units (NICU), adult ICUs, and emergency departments. With the increasing clinical demand, the application of inhaled nitric oxide in various respiratory diseases has a promising future, especially in promoting recovery in patients with acute lung injury.
The inhaled nitric oxide market continues to grow globally, driven by several factors. Firstly, with the rising incidence of respiratory diseases, particularly in neonatal and elderly populations, the demand for inhaled nitric oxide is increasing. Inhaled nitric oxide can significantly improve clinical symptoms in patients with acute respiratory distress syndrome and other pulmonary diseases, shorten hospital stays, and improve quality of life, thereby generating strong market demand.
Secondly, technological advancements are driving market growth. New delivery devices continue to emerge, enhancing the therapeutic efficacy and safety of inhaled nitric oxide. For example, convenient gas concentration regulation systems allow patients to precisely control their inhaled dosage, thus reducing side effects. Additionally, clinical research has shown that inhaled nitric oxide is effective not only in neonates but also in adult critically ill patients, demonstrating promising therapeutic potential.
However, the market also faces some challenges and risks. Firstly, the high cost of inhaled nitric oxide remains a significant barrier to widespread adoption, particularly in developing countries, where the expensive treatment cost limits its accessibility. Secondly, while inhaled nitric oxide has been widely used in treating specific diseases, its efficacy and safety still require further clinical data, especially in atypical cases.
The market concentration is relatively high, dominated by a few leading pharmaceutical and medical device companies, which have extensive experience in product development, marketing, and clinical trials. In the future, as technology advances and treatment methods become more widespread, market concentration may decrease. The downstream demand trend reflects a growing need for more personalized and efficient treatment methods, driving the development of customized devices and new drugs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.
The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mallinckrodt (INOmax)
Linde (Noxivent)
Air Liquide (KINOX)
Segment by Type
High Purity iNO
Standard Purity iNO
Segment by Application
Infants PPHN
ARDS
Other Diseases
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Inhaled Nitric Oxide competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Inhaled Nitric Oxide (iNO) is a gas therapy widely used in the treatment of respiratory diseases, particularly neonatal respiratory distress syndrome (NRDS) and acute respiratory distress syndrome (ARDS) in adults. As a vasodilator, nitric oxide works by dilating the small blood vessels in the lungs, improving the matching of ventilation and blood flow in the alveoli, which in turn enhances oxygenation and reduces pulmonary arterial pressure. The therapeutic mechanism of inhaled nitric oxide primarily relies on its direct action on the smooth muscle of the pulmonary vessels, promoting the release of nitric oxide and thereby improving the vessel's ability to dilate, effectively improving the patient's oxygenation and respiratory function.
Currently, the products of inhaled nitric oxide mainly consist of gas formulations and related delivery devices, such as inhalers and gas concentration regulation systems. These products have been approved in many countries and regions and are widely used in neonatal intensive care units (NICU), adult ICUs, and emergency departments. With the increasing clinical demand, the application of inhaled nitric oxide in various respiratory diseases has a promising future, especially in promoting recovery in patients with acute lung injury.
The inhaled nitric oxide market continues to grow globally, driven by several factors. Firstly, with the rising incidence of respiratory diseases, particularly in neonatal and elderly populations, the demand for inhaled nitric oxide is increasing. Inhaled nitric oxide can significantly improve clinical symptoms in patients with acute respiratory distress syndrome and other pulmonary diseases, shorten hospital stays, and improve quality of life, thereby generating strong market demand.
Secondly, technological advancements are driving market growth. New delivery devices continue to emerge, enhancing the therapeutic efficacy and safety of inhaled nitric oxide. For example, convenient gas concentration regulation systems allow patients to precisely control their inhaled dosage, thus reducing side effects. Additionally, clinical research has shown that inhaled nitric oxide is effective not only in neonates but also in adult critically ill patients, demonstrating promising therapeutic potential.
However, the market also faces some challenges and risks. Firstly, the high cost of inhaled nitric oxide remains a significant barrier to widespread adoption, particularly in developing countries, where the expensive treatment cost limits its accessibility. Secondly, while inhaled nitric oxide has been widely used in treating specific diseases, its efficacy and safety still require further clinical data, especially in atypical cases.
The market concentration is relatively high, dominated by a few leading pharmaceutical and medical device companies, which have extensive experience in product development, marketing, and clinical trials. In the future, as technology advances and treatment methods become more widespread, market concentration may decrease. The downstream demand trend reflects a growing need for more personalized and efficient treatment methods, driving the development of customized devices and new drugs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Inhaled Nitric Oxide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Nitric Oxide.
The Inhaled Nitric Oxide market size, estimations, and forecasts are provided in terms of sales volume (M L) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inhaled Nitric Oxide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inhaled Nitric Oxide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Mallinckrodt (INOmax)
Linde (Noxivent)
Air Liquide (KINOX)
Segment by Type
High Purity iNO
Standard Purity iNO
Segment by Application
Infants PPHN
ARDS
Other Diseases
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Inhaled Nitric Oxide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Inhaled Nitric Oxide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Inhaled Nitric Oxide Market Overview
1.1 Product Definition
1.2 Inhaled Nitric Oxide by Type
1.2.1 Global Inhaled Nitric Oxide Market Value Comparison by Type (2024 VS 2031)
1.2.2 High Purity iNO
1.2.3 Standard Purity iNO
1.3 Inhaled Nitric Oxide by Application
1.3.1 Global Inhaled Nitric Oxide Market Value by Application (2024 VS 2031)
1.3.2 Infants PPHN
1.3.3 ARDS
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Revenue 2020-2031
1.4.2 Global Inhaled Nitric Oxide Sales 2020-2031
1.4.3 Global Inhaled Nitric Oxide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhaled Nitric Oxide Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhaled Nitric Oxide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhaled Nitric Oxide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
2.7 Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
2.8 Global Inhaled Nitric Oxide Market Competitive Situation and Trends
2.8.1 Global Inhaled Nitric Oxide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhaled Nitric Oxide Players Market Share by Revenue
2.8.3 Global Inhaled Nitric Oxide Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhaled Nitric Oxide Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhaled Nitric Oxide Sales by Region: 2020-2031
3.2.1 Global Inhaled Nitric Oxide Sales by Region: 2020-2025
3.2.2 Global Inhaled Nitric Oxide Sales by Region: 2026-2031
3.3 Global Inhaled Nitric Oxide Revenue by Region: 2020-2031
3.3.1 Global Inhaled Nitric Oxide Revenue by Region: 2020-2025
3.3.2 Global Inhaled Nitric Oxide Revenue by Region: 2026-2031
3.4 North America Inhaled Nitric Oxide Market Facts & Figures by Country
3.4.1 North America Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhaled Nitric Oxide Sales by Country (2020-2031)
3.4.3 North America Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
3.5.1 Europe Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhaled Nitric Oxide Sales by Country (2020-2031)
3.5.3 Europe Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaled Nitric Oxide Market Facts & Figures by Region
3.6.1 Asia Pacific Inhaled Nitric Oxide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhaled Nitric Oxide Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhaled Nitric Oxide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
3.7.1 Latin America Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhaled Nitric Oxide Sales by Country (2020-2031)
3.7.3 Latin America Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inhaled Nitric Oxide Sales by Type (2020-2031)
4.1.1 Global Inhaled Nitric Oxide Sales by Type (2020-2025)
4.1.2 Global Inhaled Nitric Oxide Sales by Type (2026-2031)
4.1.3 Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2031)
4.2 Global Inhaled Nitric Oxide Revenue by Type (2020-2031)
4.2.1 Global Inhaled Nitric Oxide Revenue by Type (2020-2025)
4.2.2 Global Inhaled Nitric Oxide Revenue by Type (2026-2031)
4.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2031)
4.3 Global Inhaled Nitric Oxide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhaled Nitric Oxide Sales by Application (2020-2031)
5.1.1 Global Inhaled Nitric Oxide Sales by Application (2020-2025)
5.1.2 Global Inhaled Nitric Oxide Sales by Application (2026-2031)
5.1.3 Global Inhaled Nitric Oxide Sales Market Share by Application (2020-2031)
5.2 Global Inhaled Nitric Oxide Revenue by Application (2020-2031)
5.2.1 Global Inhaled Nitric Oxide Revenue by Application (2020-2025)
5.2.2 Global Inhaled Nitric Oxide Revenue by Application (2026-2031)
5.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Application (2020-2031)
5.3 Global Inhaled Nitric Oxide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mallinckrodt (INOmax)
6.1.1 Mallinckrodt (INOmax) Company Information
6.1.2 Mallinckrodt (INOmax) Description and Business Overview
6.1.3 Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mallinckrodt (INOmax) Inhaled Nitric Oxide Product Portfolio
6.1.5 Mallinckrodt (INOmax) Recent Developments/Updates
6.2 Linde (Noxivent)
6.2.1 Linde (Noxivent) Company Information
6.2.2 Linde (Noxivent) Description and Business Overview
6.2.3 Linde (Noxivent) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Linde (Noxivent) Inhaled Nitric Oxide Product Portfolio
6.2.5 Linde (Noxivent) Recent Developments/Updates
6.3 Air Liquide (KINOX)
6.3.1 Air Liquide (KINOX) Company Information
6.3.2 Air Liquide (KINOX) Description and Business Overview
6.3.3 Air Liquide (KINOX) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Air Liquide (KINOX) Inhaled Nitric Oxide Product Portfolio
6.3.5 Air Liquide (KINOX) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaled Nitric Oxide Industry Chain Analysis
7.2 Inhaled Nitric Oxide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaled Nitric Oxide Production Mode & Process Analysis
7.4 Inhaled Nitric Oxide Sales and Marketing
7.4.1 Inhaled Nitric Oxide Sales Channels
7.4.2 Inhaled Nitric Oxide Distributors
7.5 Inhaled Nitric Oxide Customer Analysis
8 Inhaled Nitric Oxide Market Dynamics
8.1 Inhaled Nitric Oxide Industry Trends
8.2 Inhaled Nitric Oxide Market Drivers
8.3 Inhaled Nitric Oxide Market Challenges
8.4 Inhaled Nitric Oxide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Inhaled Nitric Oxide by Type
1.2.1 Global Inhaled Nitric Oxide Market Value Comparison by Type (2024 VS 2031)
1.2.2 High Purity iNO
1.2.3 Standard Purity iNO
1.3 Inhaled Nitric Oxide by Application
1.3.1 Global Inhaled Nitric Oxide Market Value by Application (2024 VS 2031)
1.3.2 Infants PPHN
1.3.3 ARDS
1.3.4 Other Diseases
1.4 Global Inhaled Nitric Oxide Market Size Estimates and Forecasts
1.4.1 Global Inhaled Nitric Oxide Revenue 2020-2031
1.4.2 Global Inhaled Nitric Oxide Sales 2020-2031
1.4.3 Global Inhaled Nitric Oxide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Inhaled Nitric Oxide Market Competition by Manufacturers
2.1 Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Inhaled Nitric Oxide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Inhaled Nitric Oxide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Inhaled Nitric Oxide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
2.7 Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
2.8 Global Inhaled Nitric Oxide Market Competitive Situation and Trends
2.8.1 Global Inhaled Nitric Oxide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Inhaled Nitric Oxide Players Market Share by Revenue
2.8.3 Global Inhaled Nitric Oxide Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Inhaled Nitric Oxide Market Scenario by Region
3.1 Global Inhaled Nitric Oxide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Inhaled Nitric Oxide Sales by Region: 2020-2031
3.2.1 Global Inhaled Nitric Oxide Sales by Region: 2020-2025
3.2.2 Global Inhaled Nitric Oxide Sales by Region: 2026-2031
3.3 Global Inhaled Nitric Oxide Revenue by Region: 2020-2031
3.3.1 Global Inhaled Nitric Oxide Revenue by Region: 2020-2025
3.3.2 Global Inhaled Nitric Oxide Revenue by Region: 2026-2031
3.4 North America Inhaled Nitric Oxide Market Facts & Figures by Country
3.4.1 North America Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Inhaled Nitric Oxide Sales by Country (2020-2031)
3.4.3 North America Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inhaled Nitric Oxide Market Facts & Figures by Country
3.5.1 Europe Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Inhaled Nitric Oxide Sales by Country (2020-2031)
3.5.3 Europe Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inhaled Nitric Oxide Market Facts & Figures by Region
3.6.1 Asia Pacific Inhaled Nitric Oxide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Inhaled Nitric Oxide Sales by Region (2020-2031)
3.6.3 Asia Pacific Inhaled Nitric Oxide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inhaled Nitric Oxide Market Facts & Figures by Country
3.7.1 Latin America Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Inhaled Nitric Oxide Sales by Country (2020-2031)
3.7.3 Latin America Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inhaled Nitric Oxide Market Facts & Figures by Country
3.8.1 Middle East and Africa Inhaled Nitric Oxide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inhaled Nitric Oxide Sales by Type (2020-2031)
4.1.1 Global Inhaled Nitric Oxide Sales by Type (2020-2025)
4.1.2 Global Inhaled Nitric Oxide Sales by Type (2026-2031)
4.1.3 Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2031)
4.2 Global Inhaled Nitric Oxide Revenue by Type (2020-2031)
4.2.1 Global Inhaled Nitric Oxide Revenue by Type (2020-2025)
4.2.2 Global Inhaled Nitric Oxide Revenue by Type (2026-2031)
4.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2031)
4.3 Global Inhaled Nitric Oxide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Inhaled Nitric Oxide Sales by Application (2020-2031)
5.1.1 Global Inhaled Nitric Oxide Sales by Application (2020-2025)
5.1.2 Global Inhaled Nitric Oxide Sales by Application (2026-2031)
5.1.3 Global Inhaled Nitric Oxide Sales Market Share by Application (2020-2031)
5.2 Global Inhaled Nitric Oxide Revenue by Application (2020-2031)
5.2.1 Global Inhaled Nitric Oxide Revenue by Application (2020-2025)
5.2.2 Global Inhaled Nitric Oxide Revenue by Application (2026-2031)
5.2.3 Global Inhaled Nitric Oxide Revenue Market Share by Application (2020-2031)
5.3 Global Inhaled Nitric Oxide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Mallinckrodt (INOmax)
6.1.1 Mallinckrodt (INOmax) Company Information
6.1.2 Mallinckrodt (INOmax) Description and Business Overview
6.1.3 Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Mallinckrodt (INOmax) Inhaled Nitric Oxide Product Portfolio
6.1.5 Mallinckrodt (INOmax) Recent Developments/Updates
6.2 Linde (Noxivent)
6.2.1 Linde (Noxivent) Company Information
6.2.2 Linde (Noxivent) Description and Business Overview
6.2.3 Linde (Noxivent) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Linde (Noxivent) Inhaled Nitric Oxide Product Portfolio
6.2.5 Linde (Noxivent) Recent Developments/Updates
6.3 Air Liquide (KINOX)
6.3.1 Air Liquide (KINOX) Company Information
6.3.2 Air Liquide (KINOX) Description and Business Overview
6.3.3 Air Liquide (KINOX) Inhaled Nitric Oxide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Air Liquide (KINOX) Inhaled Nitric Oxide Product Portfolio
6.3.5 Air Liquide (KINOX) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inhaled Nitric Oxide Industry Chain Analysis
7.2 Inhaled Nitric Oxide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inhaled Nitric Oxide Production Mode & Process Analysis
7.4 Inhaled Nitric Oxide Sales and Marketing
7.4.1 Inhaled Nitric Oxide Sales Channels
7.4.2 Inhaled Nitric Oxide Distributors
7.5 Inhaled Nitric Oxide Customer Analysis
8 Inhaled Nitric Oxide Market Dynamics
8.1 Inhaled Nitric Oxide Industry Trends
8.2 Inhaled Nitric Oxide Market Drivers
8.3 Inhaled Nitric Oxide Market Challenges
8.4 Inhaled Nitric Oxide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Inhaled Nitric Oxide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Inhaled Nitric Oxide Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Inhaled Nitric Oxide Market Competitive Situation by Manufacturers in 2024
Table 4. Global Inhaled Nitric Oxide Sales (M L) of Key Manufacturers (2020-2025)
Table 5. Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Inhaled Nitric Oxide Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Inhaled Nitric Oxide Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Inhaled Nitric Oxide Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Inhaled Nitric Oxide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
Table 12. Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 18. Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
Table 19. Global Inhaled Nitric Oxide Sales by Region (2026-2031) & (M L)
Table 20. Global Inhaled Nitric Oxide Sales Market Share by Region (2026-2031)
Table 21. Global Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2025)
Table 23. Global Inhaled Nitric Oxide Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Inhaled Nitric Oxide Revenue Market Share by Region (2026-2031)
Table 25. North America Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 27. North America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 28. North America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 32. Europe Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 33. Europe Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Inhaled Nitric Oxide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 37. Asia Pacific Inhaled Nitric Oxide Sales by Region (2026-2031) & (M L)
Table 38. Asia Pacific Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Inhaled Nitric Oxide Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 42. Latin America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 43. Latin America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 47. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 48. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Inhaled Nitric Oxide Sales (M L) by Type (2020-2025)
Table 51. Global Inhaled Nitric Oxide Sales (M L) by Type (2026-2031)
Table 52. Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Table 53. Global Inhaled Nitric Oxide Sales Market Share by Type (2026-2031)
Table 54. Global Inhaled Nitric Oxide Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Inhaled Nitric Oxide Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2025)
Table 57. Global Inhaled Nitric Oxide Revenue Market Share by Type (2026-2031)
Table 58. Global Inhaled Nitric Oxide Price (US$/L) by Type (2020-2025)
Table 59. Global Inhaled Nitric Oxide Price (US$/L) by Type (2026-2031)
Table 60. Global Inhaled Nitric Oxide Sales (M L) by Application (2020-2025)
Table 61. Global Inhaled Nitric Oxide Sales (M L) by Application (2026-2031)
Table 62. Global Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Table 63. Global Inhaled Nitric Oxide Sales Market Share by Application (2026-2031)
Table 64. Global Inhaled Nitric Oxide Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Inhaled Nitric Oxide Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Inhaled Nitric Oxide Revenue Market Share by Application (2020-2025)
Table 67. Global Inhaled Nitric Oxide Revenue Market Share by Application (2026-2031)
Table 68. Global Inhaled Nitric Oxide Price (US$/L) by Application (2020-2025)
Table 69. Global Inhaled Nitric Oxide Price (US$/L) by Application (2026-2031)
Table 70. Mallinckrodt (INOmax) Company Information
Table 71. Mallinckrodt (INOmax) Description and Business Overview
Table 72. Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. Mallinckrodt (INOmax) Inhaled Nitric Oxide Product
Table 74. Mallinckrodt (INOmax) Recent Developments/Updates
Table 75. Linde (Noxivent) Company Information
Table 76. Linde (Noxivent) Description and Business Overview
Table 77. Linde (Noxivent) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Linde (Noxivent) Inhaled Nitric Oxide Product
Table 79. Linde (Noxivent) Recent Developments/Updates
Table 80. Air Liquide (KINOX) Company Information
Table 81. Air Liquide (KINOX) Description and Business Overview
Table 82. Air Liquide (KINOX) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Air Liquide (KINOX) Inhaled Nitric Oxide Product
Table 84. Air Liquide (KINOX) Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Inhaled Nitric Oxide Distributors List
Table 88. Inhaled Nitric Oxide Customers List
Table 89. Inhaled Nitric Oxide Market Trends
Table 90. Inhaled Nitric Oxide Market Drivers
Table 91. Inhaled Nitric Oxide Market Challenges
Table 92. Inhaled Nitric Oxide Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inhaled Nitric Oxide
Figure 2. Global Inhaled Nitric Oxide Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inhaled Nitric Oxide Market Share by Type: 2024 & 2031
Figure 4. High Purity iNO Product Picture
Figure 5. Standard Purity iNO Product Picture
Figure 6. Global Inhaled Nitric Oxide Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Inhaled Nitric Oxide Market Share by Application: 2024 & 2031
Figure 8. Infants PPHN
Figure 9. ARDS
Figure 10. Other Diseases
Figure 11. Global Inhaled Nitric Oxide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Inhaled Nitric Oxide Market Size (2020-2031) & (US$ Million)
Figure 13. Global Inhaled Nitric Oxide Sales (2020-2031) & (M L)
Figure 14. Global Inhaled Nitric Oxide Average Price (US$/L) & (2020-2031)
Figure 15. Inhaled Nitric Oxide Report Years Considered
Figure 16. Inhaled Nitric Oxide Sales Share by Manufacturers in 2024
Figure 17. Global Inhaled Nitric Oxide Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Inhaled Nitric Oxide Players: Market Share by Revenue in Inhaled Nitric Oxide in 2024
Figure 19. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 22. North America Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 26. Europe Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 27. Germany Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Inhaled Nitric Oxide Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
Figure 34. China Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 45. Latin America Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Inhaled Nitric Oxide by Type (2020-2031)
Figure 55. Global Revenue Market Share of Inhaled Nitric Oxide by Type (2020-2031)
Figure 56. Global Inhaled Nitric Oxide Price (US$/L) by Type (2020-2031)
Figure 57. Global Sales Market Share of Inhaled Nitric Oxide by Application (2020-2031)
Figure 58. Global Revenue Market Share of Inhaled Nitric Oxide by Application (2020-2031)
Figure 59. Global Inhaled Nitric Oxide Price (US$/L) by Application (2020-2031)
Figure 60. Inhaled Nitric Oxide Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Inhaled Nitric Oxide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Inhaled Nitric Oxide Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Inhaled Nitric Oxide Market Competitive Situation by Manufacturers in 2024
Table 4. Global Inhaled Nitric Oxide Sales (M L) of Key Manufacturers (2020-2025)
Table 5. Global Inhaled Nitric Oxide Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Inhaled Nitric Oxide Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Inhaled Nitric Oxide Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Inhaled Nitric Oxide Average Price (US$/L) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Inhaled Nitric Oxide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Inhaled Nitric Oxide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inhaled Nitric Oxide, Product Type & Application
Table 12. Global Key Manufacturers of Inhaled Nitric Oxide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inhaled Nitric Oxide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inhaled Nitric Oxide as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 18. Global Inhaled Nitric Oxide Sales Market Share by Region (2020-2025)
Table 19. Global Inhaled Nitric Oxide Sales by Region (2026-2031) & (M L)
Table 20. Global Inhaled Nitric Oxide Sales Market Share by Region (2026-2031)
Table 21. Global Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Inhaled Nitric Oxide Revenue Market Share by Region (2020-2025)
Table 23. Global Inhaled Nitric Oxide Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Inhaled Nitric Oxide Revenue Market Share by Region (2026-2031)
Table 25. North America Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 27. North America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 28. North America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 32. Europe Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 33. Europe Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Inhaled Nitric Oxide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Inhaled Nitric Oxide Sales by Region (2020-2025) & (M L)
Table 37. Asia Pacific Inhaled Nitric Oxide Sales by Region (2026-2031) & (M L)
Table 38. Asia Pacific Inhaled Nitric Oxide Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Inhaled Nitric Oxide Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 42. Latin America Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 43. Latin America Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Inhaled Nitric Oxide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2020-2025) & (M L)
Table 47. Middle East and Africa Inhaled Nitric Oxide Sales by Country (2026-2031) & (M L)
Table 48. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Inhaled Nitric Oxide Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Inhaled Nitric Oxide Sales (M L) by Type (2020-2025)
Table 51. Global Inhaled Nitric Oxide Sales (M L) by Type (2026-2031)
Table 52. Global Inhaled Nitric Oxide Sales Market Share by Type (2020-2025)
Table 53. Global Inhaled Nitric Oxide Sales Market Share by Type (2026-2031)
Table 54. Global Inhaled Nitric Oxide Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Inhaled Nitric Oxide Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Inhaled Nitric Oxide Revenue Market Share by Type (2020-2025)
Table 57. Global Inhaled Nitric Oxide Revenue Market Share by Type (2026-2031)
Table 58. Global Inhaled Nitric Oxide Price (US$/L) by Type (2020-2025)
Table 59. Global Inhaled Nitric Oxide Price (US$/L) by Type (2026-2031)
Table 60. Global Inhaled Nitric Oxide Sales (M L) by Application (2020-2025)
Table 61. Global Inhaled Nitric Oxide Sales (M L) by Application (2026-2031)
Table 62. Global Inhaled Nitric Oxide Sales Market Share by Application (2020-2025)
Table 63. Global Inhaled Nitric Oxide Sales Market Share by Application (2026-2031)
Table 64. Global Inhaled Nitric Oxide Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Inhaled Nitric Oxide Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Inhaled Nitric Oxide Revenue Market Share by Application (2020-2025)
Table 67. Global Inhaled Nitric Oxide Revenue Market Share by Application (2026-2031)
Table 68. Global Inhaled Nitric Oxide Price (US$/L) by Application (2020-2025)
Table 69. Global Inhaled Nitric Oxide Price (US$/L) by Application (2026-2031)
Table 70. Mallinckrodt (INOmax) Company Information
Table 71. Mallinckrodt (INOmax) Description and Business Overview
Table 72. Mallinckrodt (INOmax) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 73. Mallinckrodt (INOmax) Inhaled Nitric Oxide Product
Table 74. Mallinckrodt (INOmax) Recent Developments/Updates
Table 75. Linde (Noxivent) Company Information
Table 76. Linde (Noxivent) Description and Business Overview
Table 77. Linde (Noxivent) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 78. Linde (Noxivent) Inhaled Nitric Oxide Product
Table 79. Linde (Noxivent) Recent Developments/Updates
Table 80. Air Liquide (KINOX) Company Information
Table 81. Air Liquide (KINOX) Description and Business Overview
Table 82. Air Liquide (KINOX) Inhaled Nitric Oxide Sales (M L), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
Table 83. Air Liquide (KINOX) Inhaled Nitric Oxide Product
Table 84. Air Liquide (KINOX) Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. Inhaled Nitric Oxide Distributors List
Table 88. Inhaled Nitric Oxide Customers List
Table 89. Inhaled Nitric Oxide Market Trends
Table 90. Inhaled Nitric Oxide Market Drivers
Table 91. Inhaled Nitric Oxide Market Challenges
Table 92. Inhaled Nitric Oxide Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of Inhaled Nitric Oxide
Figure 2. Global Inhaled Nitric Oxide Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Inhaled Nitric Oxide Market Share by Type: 2024 & 2031
Figure 4. High Purity iNO Product Picture
Figure 5. Standard Purity iNO Product Picture
Figure 6. Global Inhaled Nitric Oxide Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Inhaled Nitric Oxide Market Share by Application: 2024 & 2031
Figure 8. Infants PPHN
Figure 9. ARDS
Figure 10. Other Diseases
Figure 11. Global Inhaled Nitric Oxide Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Inhaled Nitric Oxide Market Size (2020-2031) & (US$ Million)
Figure 13. Global Inhaled Nitric Oxide Sales (2020-2031) & (M L)
Figure 14. Global Inhaled Nitric Oxide Average Price (US$/L) & (2020-2031)
Figure 15. Inhaled Nitric Oxide Report Years Considered
Figure 16. Inhaled Nitric Oxide Sales Share by Manufacturers in 2024
Figure 17. Global Inhaled Nitric Oxide Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Inhaled Nitric Oxide Players: Market Share by Revenue in Inhaled Nitric Oxide in 2024
Figure 19. Inhaled Nitric Oxide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Inhaled Nitric Oxide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 22. North America Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 26. Europe Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 27. Germany Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Inhaled Nitric Oxide Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Inhaled Nitric Oxide Revenue Market Share by Region (2020-2031)
Figure 34. China Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 45. Latin America Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Inhaled Nitric Oxide Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Inhaled Nitric Oxide Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. U.A.E Inhaled Nitric Oxide Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Inhaled Nitric Oxide by Type (2020-2031)
Figure 55. Global Revenue Market Share of Inhaled Nitric Oxide by Type (2020-2031)
Figure 56. Global Inhaled Nitric Oxide Price (US$/L) by Type (2020-2031)
Figure 57. Global Sales Market Share of Inhaled Nitric Oxide by Application (2020-2031)
Figure 58. Global Revenue Market Share of Inhaled Nitric Oxide by Application (2020-2031)
Figure 59. Global Inhaled Nitric Oxide Price (US$/L) by Application (2020-2031)
Figure 60. Inhaled Nitric Oxide Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Medical Waste Fluid Solidifier Market Research Report 2025
Jun 12, 25
Global Metalized Bubble Material Market Research Report 2025
Jun 12, 25
Global 70% Isopropyl Rubbing Alcohol Market Research Report 2025
Jun 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232